| Product NDC: | 0009-0626 |
| Proprietary Name: | Depo-Provera |
| Non Proprietary Name: | medroxyprogesterone acetate |
| Active Ingredient(s): | 400 mg/mL & nbsp; medroxyprogesterone acetate |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0009-0626 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA012541 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19601101 |
| Package NDC: | 0009-0626-01 |
| Package Description: | 2.5 mL in 1 VIAL (0009-0626-01) |
| NDC Code | 0009-0626-01 |
| Proprietary Name | Depo-Provera |
| Package Description | 2.5 mL in 1 VIAL (0009-0626-01) |
| Product NDC | 0009-0626 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | medroxyprogesterone acetate |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19601101 |
| Marketing Category Name | NDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | MEDROXYPROGESTERONE ACETATE |
| Strength Number | 400 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |